Exact Mass: 706.197

Exact Mass Matches: 706.197

Found 12 metabolites which its exact mass value is equals to given mass value 706.197, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Epicatechin-(2alpha->7,4alpha->8)-epicatechin 3-galactoside

(2R,3R,4S,5R,6R)-2-{[(1R,5S,13R,21R)-5,13-bis(3,4-dihydroxyphenyl)-17,19-dihydroxy-4,12,14-trioxapentacyclo[11.7.1.0²,¹¹.0³,⁸.0¹⁵,²⁰]henicosa-2(11),3(8),9,15(20),16,18-hexaen-21-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C36H34O15 (706.1898)

Epicatechin-(2alpha->7,4alpha->8)-epicatechin 3-galactoside is a member of the class of compounds known as biflavonoids and polyflavonoids. Biflavonoids and polyflavonoids are organic compounds containing at least two flavan/flavone units. These units are usually linked through CC or C-O-C bonds. Some examples include C2-O-C3, C2-O-C4, C3-C3, and C6-C8. Epicatechin-(2alpha->7,4alpha->8)-epicatechin 3-galactoside is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Epicatechin-(2alpha->7,4alpha->8)-epicatechin 3-galactoside can be found in chocolate and cocoa powder, which makes epicatechin-(2alpha->7,4alpha->8)-epicatechin 3-galactoside a potential biomarker for the consumption of these food products.

ent-epiafzelechin-(2alpha?O?7,4alpha?8)-ent-afzelechin 3?-O-beta-D-glucopyranoside

C36H34O15 (706.1898)

(-)-Epicatechin-(2a-7)(4a-8)-epicatechin 3-O-galactoside

C36H34O15 (706.1898)

Viridaphin A1 Glucoside

C36H34O15 (706.1898)

A natural product found in Megoura crassicauda.

3,4,5-trihydroxy-6-[[3-hydroxy-2-(3-hydroxyphenyl)-4-[3,5,7-trihydroxy-2-(3-hydroxyphenyl)-3,4-dihydro-2H-chromen-8-yl]-3,4-dihydro-2H-chromen-7-yl]oxy]oxane-2-carboxylic acid

C36H34O15 (706.1898)

4,10,14-trihydroxy-5-[(1s,9s)-5-hydroxy-9-methyl-8-oxatricyclo[7.3.1.0²,⁷]trideca-2,4,6,10-tetraen-11-yl]-1-(3-methylbut-2-en-1-yl)-2-oxo-9,17-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁶]heptadeca-3,5,7,11,13,15-hexaen-6-yl 2,4-dihydroxybenzoate

4,10,14-trihydroxy-5-[(1s,9s)-5-hydroxy-9-methyl-8-oxatricyclo[7.3.1.0²,⁷]trideca-2,4,6,10-tetraen-11-yl]-1-(3-methylbut-2-en-1-yl)-2-oxo-9,17-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁶]heptadeca-3,5,7,11,13,15-hexaen-6-yl 2,4-dihydroxybenzoate

C40H34O12 (706.205)

(2s,3s,4s,5r,6s)-6-{4-[(r)-[(3s)-3-[(2-{4-[(3r)-3-amino-3-carboxypropoxy]phenyl}-1,2-dihydroxyethylidene)amino]-3-[(hydroxymethylidene)amino]-2-oxoazetidin-1-yl](carboxy)methyl]phenoxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

(2s,3s,4s,5r,6s)-6-{4-[(r)-[(3s)-3-[(2-{4-[(3r)-3-amino-3-carboxypropoxy]phenyl}-1,2-dihydroxyethylidene)amino]-3-[(hydroxymethylidene)amino]-2-oxoazetidin-1-yl](carboxy)methyl]phenoxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C30H34N4O16 (706.197)

6-(4-{[3-({2-[4-(3-amino-3-carboxypropoxy)phenyl]-1,2-dihydroxyethylidene}amino)-3-[(hydroxymethylidene)amino]-2-oxoazetidin-1-yl](carboxy)methyl}phenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

C30H34N4O16 (706.197)

(1s,10s)-4,10,14-trihydroxy-5-[(1r,9s)-5-hydroxy-9-methyl-8-oxatricyclo[7.3.1.0²,⁷]trideca-2,4,6,10-tetraen-11-yl]-1-(3-methylbut-2-en-1-yl)-2-oxo-9,17-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁶]heptadeca-3,5,7,11,13,15-hexaen-6-yl 2,4-dihydroxybenzoate

(1s,10s)-4,10,14-trihydroxy-5-[(1r,9s)-5-hydroxy-9-methyl-8-oxatricyclo[7.3.1.0²,⁷]trideca-2,4,6,10-tetraen-11-yl]-1-(3-methylbut-2-en-1-yl)-2-oxo-9,17-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁶]heptadeca-3,5,7,11,13,15-hexaen-6-yl 2,4-dihydroxybenzoate

C40H34O12 (706.205)